Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adipocytokine signaling pathway 💬 16 genes, 38 drugs (DrugBank) and 104 diseases |
JAK2 1件: JAK2 💬Adipocytokine signaling pathway
|
Baricitinib Baricitinib 💬Adipocytokine signaling pathway
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬1. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
JAK2 1件: JAK2 💬AGE-RAGE signaling pathway in diabetic complications
|
Baricitinib Baricitinib 💬AGE-RAGE signaling pathway in diabetic complications
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬2. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
JAK2 1件: JAK2 💬Chemical carcinogenesis - receptor activation
|
Baricitinib Baricitinib 💬Chemical carcinogenesis - receptor activation
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬3. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Chemokine signaling pathway 💬 23 genes, 38 drugs (DrugBank) and 64 diseases |
JAK2 1件: JAK2 💬Chemokine signaling pathway
|
Baricitinib Baricitinib 💬Chemokine signaling pathway
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬4. Chemokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
JAK2 1件: JAK2 💬Cholinergic synapse
|
Baricitinib Baricitinib 💬Cholinergic synapse
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬5. Cholinergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
JAK1 1件: JAK1 💬Coronavirus disease - COVID-19
|
Baricitinib Baricitinib 💬Coronavirus disease - COVID-19
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬6. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Efferocytosis 💬 29 genes, 74 drugs (DrugBank) and 93 diseases |
JAK2 1件: JAK2 💬Efferocytosis
|
Baricitinib Baricitinib 💬Efferocytosis
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬7. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Epstein-Barr virus infection 💬 67 genes, 90 drugs (DrugBank) and 82 diseases |
JAK1 1件: JAK1 💬Epstein-Barr virus infection
|
Baricitinib Baricitinib 💬Epstein-Barr virus infection
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬8. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
JAK2 1件: JAK2 💬Growth hormone synthesis, secretion and action
|
Baricitinib Baricitinib 💬Growth hormone synthesis, secretion and action
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬9. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Hepatitis B 💬 43 genes, 65 drugs (DrugBank) and 87 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Hepatitis B
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬10. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
JAK1 1件: JAK1 💬Hepatitis C
|
Baricitinib Baricitinib 💬Hepatitis C
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬11. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Herpes simplex virus 1 infection
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬12. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
JAK2 1件: JAK2 💬Hormone signaling
|
Baricitinib Baricitinib 💬Hormone signaling
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬13. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
JAK1 1件: JAK1 💬Human cytomegalovirus infection
|
Baricitinib Baricitinib 💬Human cytomegalovirus infection
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬14. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
JAK1 1件: JAK1 💬Human papillomavirus infection
|
Baricitinib Baricitinib 💬Human papillomavirus infection
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬15. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
JAK1 1件: JAK1 💬Human T-cell leukemia virus 1 infection
|
Baricitinib Baricitinib 💬Human T-cell leukemia virus 1 infection
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬16. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Influenza A
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬17. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬JAK-STAT signaling pathway
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬18. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Kaposi sarcoma-associated herpesvirus infection
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬19. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Leishmaniasis
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬20. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
JAK2 1件: JAK2 💬Lipid and atherosclerosis
|
Baricitinib Baricitinib 💬Lipid and atherosclerosis
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬21. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Measles 💬 42 genes, 63 drugs (DrugBank) and 68 diseases |
JAK1 1件: JAK1 💬Measles
|
Baricitinib Baricitinib 💬Measles
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬22. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Necroptosis 💬 32 genes, 52 drugs (DrugBank) and 77 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Necroptosis
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬23. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | NOD-like receptor signaling pathway 💬 32 genes, 51 drugs (DrugBank) and 74 diseases |
JAK1 1件: JAK1 💬NOD-like receptor signaling pathway
|
Baricitinib Baricitinib 💬NOD-like receptor signaling pathway
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬24. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
JAK1 1件: JAK1 💬Osteoclast differentiation
|
Baricitinib Baricitinib 💬Osteoclast differentiation
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬25. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Pancreatic cancer 💬 19 genes, 40 drugs (DrugBank) and 84 diseases |
JAK1 1件: JAK1 💬Pancreatic cancer
|
Baricitinib Baricitinib 💬Pancreatic cancer
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬26. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Pathways in cancer
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬27. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 35 genes, 66 drugs (DrugBank) and 100 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬28. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬PI3K-Akt signaling pathway
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬29. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Prolactin signaling pathway 💬 19 genes, 43 drugs (DrugBank) and 70 diseases |
JAK2 1件: JAK2 💬Prolactin signaling pathway
|
Baricitinib Baricitinib 💬Prolactin signaling pathway
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬30. Prolactin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 36 drugs (DrugBank) and 62 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Signaling pathways regulating pluripotency of stem cells
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬31. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Th1 and Th2 cell differentiation 💬 46 genes, 51 drugs (DrugBank) and 77 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Th1 and Th2 cell differentiation
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬32. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Th17 cell differentiation
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬33. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
JAK1 1件: JAK1 💬Toll-like receptor signaling pathway
|
Baricitinib Baricitinib 💬Toll-like receptor signaling pathway
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬34. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Toxoplasmosis 💬 41 genes, 49 drugs (DrugBank) and 76 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Toxoplasmosis
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬35. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Tuberculosis
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬36. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Viral carcinogenesis 💬 32 genes, 31 drugs (DrugBank) and 58 diseases |
JAK1 1件: JAK1 💬Viral carcinogenesis
|
Baricitinib Baricitinib 💬Viral carcinogenesis
| Baricitinib | 002 21件: 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬37. Viral carcinogenesis
|
Adipocytokine signaling pathway
16 genes, 38 drugs (DrugBank) and 104 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Chemokine signaling pathway
23 genes, 38 drugs (DrugBank) and 64 diseases
Cholinergic synapse
32 genes, 64 drugs (DrugBank) and 81 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Efferocytosis
29 genes, 74 drugs (DrugBank) and 93 diseases
Epstein-Barr virus infection
67 genes, 90 drugs (DrugBank) and 82 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 100 diseases
Hepatitis B
43 genes, 65 drugs (DrugBank) and 87 diseases
Hepatitis C
36 genes, 70 drugs (DrugBank) and 87 diseases
Herpes simplex virus 1 infection
70 genes, 80 drugs (DrugBank) and 107 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
Human T-cell leukemia virus 1 infection
59 genes, 74 drugs (DrugBank) and 96 diseases
Influenza A
65 genes, 78 drugs (DrugBank) and 98 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
Leishmaniasis
40 genes, 68 drugs (DrugBank) and 102 diseases
Lipid and atherosclerosis
51 genes, 71 drugs (DrugBank) and 103 diseases
Measles
42 genes, 63 drugs (DrugBank) and 68 diseases
Necroptosis
32 genes, 52 drugs (DrugBank) and 77 diseases
NOD-like receptor signaling pathway
32 genes, 51 drugs (DrugBank) and 74 diseases
Osteoclast differentiation
38 genes, 86 drugs (DrugBank) and 102 diseases
Pancreatic cancer
19 genes, 40 drugs (DrugBank) and 84 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
35 genes, 66 drugs (DrugBank) and 100 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Prolactin signaling pathway
19 genes, 43 drugs (DrugBank) and 70 diseases
Signaling pathways regulating pluripotency of stem cells
21 genes, 36 drugs (DrugBank) and 62 diseases
Th1 and Th2 cell differentiation
46 genes, 51 drugs (DrugBank) and 77 diseases
Th17 cell differentiation
56 genes, 80 drugs (DrugBank) and 108 diseases
Toll-like receptor signaling pathway
41 genes, 65 drugs (DrugBank) and 79 diseases
Toxoplasmosis
41 genes, 49 drugs (DrugBank) and 76 diseases
Tuberculosis
66 genes, 73 drugs (DrugBank) and 98 diseases
Viral carcinogenesis
32 genes, 31 drugs (DrugBank) and 58 diseases
